Wright Medical Reports Preliminary Year-over-Year Revenue Growth
Wright Medical reported preliminary 4Q17 revenue of US $217.6MM, +12.7% vs. 4Q16, and full-year 2017 revenue of $745.0MM, +7.9% vs. 2016. Jan 08, 2018
ConforMIS iTotal CR in Mechanical Alignment: Independent Study Results
Study results suggest that use of ConforMI's iTotal CR Knee plus patient-specific instrumentation yields more consistent mechanical alignment than use of patient-specific cutting guides and off-the-shelf implants. Jan 05, 2018
RTI Surgical Acquiring Zyga Technology
RTI Surgical entered into an agreement to acquire Zyga Technology, developer of the SImmetry® Sacroiliac Joint Fusion system. Jan 05, 2018
OrthoPediatrics Reports Preliminary 4Q17/2017 Revenue
OrthoPediatrics announced a preliminary 4Q17 revenue range of US $11.5MM to $11.7MM, up 22% to 24% vs. 4Q16, and full-year revenue in the range of $45.4MM to $45.6MM, +22% vs. 2016. Jan 05, 2018
Zimmer Biomet Gains FDA Clearance for Sidus Stem-free Shoulder
Zimmer Biomet received FDA 510(k) clearance for the Sidus® Stem-Free total shoulder. The device will launch within 1Q18. Jan 04, 2018
NuVasive Update on COALESCE, COHERE Interbody Fusion Devices
NuVasive launched COALESCE for Thoracolumbar Interbody Fusion, and announced FDA 510(k) clearance to market the COHERE® Cervical Interbody Fusion device with expanded indications. Jan 04, 2018
Zyga Reports Initial Results in SImmetry SI Fusion Study
Initial outcomes from Zyga's EVSI study indicate a significant reduction in low back pain and opioid use in patients receiving the SImmetry® SI Joint Fusion implant. Jan 04, 2018
Conventus Orthopaedics Receives $12MM Venture Loan
Conventus Orthopaedics closed a US $12MM venture loan. Funds will support commercialization of Nitinol-based cage technology, used to treat periarticular fractures. Jan 04, 2018
OrthoPediatrics Launches Titanium PediPlates
OrthoPediatrics launched Titanium PediPlates®, expanding its physeal tethering offering. Jan 03, 2018
Histogenics and MEDINET Sign Agreement for NeoCart in Japan
Histogenics entered into an agreement with MEDINET to develop and commercialize NeoCart® cartilage repair therapy in Japan. Jan 03, 2018
